KRAS, MYC, and ARF6: inseparable relationships cooperatively promote cancer malignancy and immune evasion
Abstract Mutations in the KRAS gene and overexpression of protein products of the MYC and ARF6 genes occur frequently in cancer. Here, the inseparable relationships and cooperation of the protein products of these three genes in cancer malignancy and immune evasion are discussed. mRNAs encoded by th...
Main Author: | Hisataka Sabe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-023-01130-3 |
Similar Items
-
High expression of AMAP1, an ARF6 effector, is associated with elevated levels of PD-L1 and fibrosis of pancreatic cancer
by: Akio Tsutaho, et al.
Published: (2020-06-01) -
ADP-Ribosylation Factor 6 Pathway Acts as a Key Executor of Mesenchymal Tumor Plasticity
by: Ari Hashimoto, et al.
Published: (2023-10-01) -
Targeting Myc-driven stress vulnerability in mutant KRAS colorectal cancer
by: Hang Ruan, et al.
Published: (2022-03-01) -
Arf6-driven endocytic recycling of CD147 determines HCC malignant phenotypes
by: Shanshan Qi, et al.
Published: (2019-11-01) -
Pan-cancer analysis of ARFs family and ARF5 promoted the progression of hepatocellular carcinoma
by: Qian Li, et al.
Published: (2024-04-01)